These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31307113)

  • 1. Usefulness of immunohistochemistry for mismatch repair protein and microsatellite instability examination in adenocarcinoma and background endometrium of sporadic endometrial cancer cases.
    Saeki H; Hlaing MT; Horimoto Y; Kajino K; Ohtsuji N; Fujino K; Terao Y; Hino O
    J Obstet Gynaecol Res; 2019 Oct; 45(10):2037-2042. PubMed ID: 31307113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
    [No Abstract]   [Full Text] [Related]  

  • 3. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
    Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
    PeerJ; 2023; 11():e15920. PubMed ID: 37663290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Liu YL; Weigelt B
    Cancer; 2024 May; 130(10):1733-1746. PubMed ID: 38422006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer.
    Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm
    Mannucci A; Furniss CS; Ukaegbu C; Horiguchi M; Fehlmann T; Uno H; Yurgelun MB; Syngal S
    J Clin Oncol; 2020 Dec; 38(34):4086-4094. PubMed ID: 32997573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series.
    Loughrey MB; McGrath J; Coleman HG; Bankhead P; Maxwell P; McGready C; Bingham V; Humphries MP; Craig SG; McQuaid S; Salto-Tellez M; James JA
    Histopathology; 2021 Feb; 78(3):401-413. PubMed ID: 32791559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers.
    van der Werf-'t Lam AS; Terlouw D; Tops CM; van Kan MS; van Hest LP; Gille HJP; Duijkers FAM; Wagner A; Eikenboom EL; Letteboer TGW; de Jong MM; Bajwa-Ten Broeke SW; Bleeker FE; Gomez Garcia EB; de Wind N; van Wezel JT; Morreau H; Suerink M; Nielsen M
    Mod Pathol; 2023 Sep; 36(9):100240. PubMed ID: 37307877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer and a family history of cancer.
    Cook LS; Nelson HE; Stidley CA; Dong Y; Round PJ; Amankwah EK; Magliocco AM; Friedenreich CM
    Gynecol Oncol; 2013 Aug; 130(2):334-9. PubMed ID: 23632205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of Universal Testing in Endometrial Cancers for Microsatellite Instability Using Next-Generation Sequencing.
    Rodriguez IV; Strickland S; Wells D; Manhardt E; Konnick EQ; Garcia R; Swisher E; Kilgore M; Norquist B
    JCO Precis Oncol; 2023 Sep; 7():e2300033. PubMed ID: 37856764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous expression of mismatch repair proteins and interpretation of immunohistochemical results in colorectal cancer and endometrial cancer.
    Li X; Zhang S; Zeng J; Song SS; Liu X; Kang W; Liang M; Yang R; Li H; Liang L
    Pathol Res Pract; 2023 Aug; 248():154647. PubMed ID: 37437501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients.
    Aiob A; Kim YR; Kim K; Kim H; Kim YB; Kim DW; No JH; Seo SH; Suh DH; Park KU
    Obstet Gynecol Sci; 2023 Nov; 66(6):537-544. PubMed ID: 37839795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of mismatch-repair and microsatellite-instability status in a Chinese colorectal cancer Cohort.
    Zhang P; Wang A; Bian C; Zhang J; Jiang C; Zhou H
    Asian J Surg; 2024 Feb; 47(2):959-967. PubMed ID: 38185557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors.
    Rasmussen M; Sowter P; Gallon R; Durhuus JA; Hayes C; Andersen O; Nilbert M; Schejbel L; Høgdall E; Santibanez-Koref M; Jackson MS; Burn J; Therkildsen C
    Front Oncol; 2023; 13():1147591. PubMed ID: 37143941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
    Nádorvári ML; Lotz G; Kulka J; Kiss A; Tímár J
    Pathol Oncol Res; 2024; 30():1611719. PubMed ID: 38655493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe.
    Kelkar SS; Prabhu VS; Zhang J; Ogando YM; Roney K; Verma RP; Miles N; Marth C
    Arch Gynecol Obstet; 2024 Jun; 309(6):2833-2841. PubMed ID: 38634898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.
    Hu ZI; Shia J; Stadler ZK; Varghese AM; Capanu M; Salo-Mullen E; Lowery MA; Diaz LA; Mandelker D; Yu KH; Zervoudakis A; Kelsen DP; Iacobuzio-Donahue CA; Klimstra DS; Saltz LB; Sahin IH; O'Reilly EM
    Clin Cancer Res; 2018 Mar; 24(6):1326-1336. PubMed ID: 29367431
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer.
    Saeki H; Horimoto Y; Hlaing MT; Men Y; Rong L; Ishizuka Y; Uomori T; Yoshida E; Terao Y; Arakawa A; Saito T; Yao T
    Oncol Lett; 2024 Jan; 27(1):9. PubMed ID: 38034487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic, immunologic, and clinical analysis of the microsatellite instability phenotype in endometrial carcinoma.
    Mackinnon AC; Johnson CM; Robin A; Christiansen L; Hanbazazh M; Summey RM; Chandrashaker D; Harada S; Bradley WH
    Hum Pathol; 2023 Sep; 139():80-90. PubMed ID: 37245630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Innovative and Accurate Next-Generation Sequencing-Based Microsatellite Instability Detection Method for Colorectal and Endometrial Tumors.
    Evrard C; Cortes U; Ndiaye B; Bonnemort J; Martel M; Aguillon R; Tougeron D; Karayan-Tapon L
    Lab Invest; 2024 Feb; 104(2):100297. PubMed ID: 38008183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.